Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 6
Submit an article Journal homepage
131
Views
30
CrossRef citations to date
0
Altmetric
Research Article

CNS Prophylaxis and Treatment in Non-Hodgkin's Lymphoma: Variation in Practice and Lessons from the Literature

Rena Buckstein Department of Medicine, University of Toronto, Toronto Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue, Toronto, Ont., Canada
,
Wendy Lim Sunnybrook and Women's Health Sciences Centre, Toronto, Ont., Canada
,
Edmee Franssen Department of Hematology, McMaster University, Toronto, Ont., Canada
&
Kevin L. Imrie Department of Biostatistics, Clinical Trials Department, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont., Canada
Pages 955-962 | Published online: 01 Jul 2009

  • van Besien, K., Ha, C., Murphy, S., et al. (1998) "Risk factors, treatment and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma". Blood 91, 1178-1184.
  • Young, R., Howser, D., Anderson, T., et al. (1979) "Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy", Am. J. Med. 66, 435-443.
  • Recht, L., Straus, D., Cirrincione, C., et al. (1988) "Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis". Am. J. Med. 84, 425-435.
  • Liang, R., Chiu, E. and Loke, S. (1990) "Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors". Hematol. Oncol. 8, 141-145.
  • Litam, J., Cabanillas, F., Smith, T., et al. (1979) "Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis". Blood 54, 1249-1257.
  • Johnson, G., Oken, M., Anderson, J., et al. (1984) "Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?". Lancet 2, 685-687.
  • Levitt, J., Dawson, D., Rosenthal, D., et al. (1980) "CNS involvement in the non-Hodgkin's lymphomas". Cancer 45, 545-552.
  • Bashir, R., Bierman, P., Vose, J., et al. (1991) "Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma". Am. J. Clin. Oncal. 14, 478-482.
  • Touroutoglou, N., Dimopoulos, M., Younes, A., et al. (1995) 'Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy", J. Clin. Oncol. 13, 1361-1367.
  • Tondini, C., Fereri, A., Siracusano, L., et al. (1991) "Diffuse large cell lymphoma of the testis". J. Clin. Oncol. 17, 2854-2858.
  • Montserrat, E., Bosch, F., Lopez-Guillermo, A., et al. (1996) "CNS involvement in mantle-cell lymphoma", J. Clin. Oncol. 14, 941.
  • Bishop, P., Wilson, W., Pearson, D., et al. (1997) "CNS involvement in primary mediastinal large B-cell lymphoma". J. Clin. Oncol. 17, 2479-2485.
  • Bollen, E., Rouwer, E., Hamers, S., et al. (1997) "Central nervous system relapse in non-Hodgkin's lymphoma". Arch. Neurol. 54, 854-859.
  • Ersboll, J., Schultz, H., Birthe, L., et al. (1985) "Meningeul involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment". Scand. J. Haematol. 35, 487-496.
  • Haioun, C., Besson, C., Lepage, E., et al. (1999) "Incidence and risk factors of central nervous system (CNS) relapse in histologically aggressive non-Hodgkin's lymphoma (NHL) uniformly treated and receiving prophylaxis for CNS. A GELA study on 974 patients". Blood 94, 522a.
  • Bos, G., van Putten, W., van der Holt, B., et al. (1998) "For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group". Ann. Oncol. 9, 191-194.
  • Pectasides, D., Economopoulos, T., Kouvatseas, G., et al. (2000) "Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience". Oncology 58, 286-292.
  • Shahab, N. and Doll, D. (1999) "Teslticular lymphonia". Semin. Oncol. 26, 259-269.
  • Fonseca, R., Habermann, T, Colgan, J., et al. (2000) 'Testicular lympboma is associated with a high incidence of extranodal recurrence", Cancer 88, 269-273.
  • Desai, J., Mitnick, R., Henry, D., et al. (1999) "Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin's lymphoma". Cancer 86, 1840-1847.
  • Bleyer, W., Poplack, D. and Simon, R. (1978) ""Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms". Blood 51, 835-842.
  • Zimm, S., Collins, J., Miser, J., et al. (1984) "Cytosine arabinoside cerebrospinal fluid kinetics". Clin. Pharmacol. Ther. 35, 826-830.
  • Moser, A., PC, A., AJ, G., et al. (1999) "Intraventricular concentration times time (C X T) methotrexate and cytarabine fr patients with recurrent meningeal leukemia and lymphoma". Cancer 85, 511-516.
  • Glantz, M., Cole, B., Recht, L., et al. (1998) "High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?", J. Clin. Oncol. 16, 1561-1567.
  • Glantz, M., Lafollette, S., Jaeckle, K., et al. (1999) "Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis", J. Clin. Oncol. 17, 3110-3116.
  • Harris, N., Jaffe, E., Stein, H., et al. (1994) "A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group". Blood 84, 1361-1392.
  • Liang, R., Chiu, E. and Lake, S.L. (1990) "Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors". Hematol. Oncol. 8, 141-145.
  • Cortes, J., O'Brien, S., Pierce, S., et al. (1995) 'The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult lymphoblastic leukemia". Blood 86, 2091-2097.
  • Perez-Soler, R., Smith, T. and Cabanillas, F. (1986) "Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphoma of aggressive histologic type". Cancer 57, 971-977.
  • Wolf, M., Matthews, J., Stone, J., et al (1997) "Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group". Ann. Oncol. 8, 71-75.
  • Fisher, R., Gainer, E., Dahlberg, E., et al. (1993) "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma". N. Engl. J. Med. 328, 1002-1006.
  • Gomez, G., Barcos, M., Han, T., et al. (1987) "Cyclophosphamide, vincristine, adriamycin and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology". Cancer 60, 18-24.
  • Ginsherg, S., Anderson, J., Gottlieb, A., et al. (1987) "A randomized trial of high-dose methotrexate versus standard dose methotrexate following cyclophosphamide, doxorubicin (adriamycin). vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851". NCI Monogr. 5, 77-80.
  • Shipp, M., Yeap, B., Harrington, D., et al. (1990) "The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen". J. Clin. Oncol. 8, 84-93.
  • Zinzani, P., Magagnoli, M., Frezza, G., et al. (1999) "Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience". Leuk. Lymphoma 32, 571-576.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.